These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38040481)

  • 1. Epicardial arrhythmogenic substrate in long QT syndrome.
    Pappone C; Ciconte G; Vicedomini G; Anastasia L; Santinelli V
    Heart Rhythm; 2023 Dec; 20(12):1782-1784. PubMed ID: 38040481
    [No Abstract]   [Full Text] [Related]  

  • 2. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.
    Mathew S; Saguner AM; Schenker N; Kaiser L; Zhang P; Yashuiro Y; Lemes C; Fink T; Maurer T; Santoro F; Wohlmuth P; Reißmann B; Heeger CH; Tilz R; Wissner E; Rillig A; Metzner A; Kuck KH; Ouyang F
    J Am Heart Assoc; 2019 Mar; 8(5):e010365. PubMed ID: 30813830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Assis FR; Tandri H
    Card Electrophysiol Clin; 2020 Sep; 12(3):329-343. PubMed ID: 32771187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?
    Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A
    J Interv Card Electrophysiol; 2017 Mar; 48(2):193-199. PubMed ID: 27900527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial ablation may not be necessary in all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and frequent ventricular tachycardia.
    Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A
    Europace; 2017 Dec; 19(12):2047. PubMed ID: 28339842
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.
    Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L
    Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial ablation may not be necessary in all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and frequent ventricular tachycardia: author's reply.
    Berruezo A; Acosta J; Fernández-Armenta J
    Europace; 2017 Dec; 19(12):2047-2048. PubMed ID: 28419233
    [No Abstract]   [Full Text] [Related]  

  • 10. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful epicardial ablation of ventricular tachycardia in a patient with arrhythmogenic right ventricular cardiomyopathy.
    Akdis D; Saguner AM; Brunckhorst CB; Duru F; Haegeli LM
    Int J Cardiol; 2016 May; 211():22-4. PubMed ID: 26970960
    [No Abstract]   [Full Text] [Related]  

  • 13. Epicardial Ventricular Tachycardia Ablation in a Patient With Brugada ECG Pattern and Mutation of PKP2 and DSP Genes.
    Forkmann M; Tomala J; Huo Y; Mayer J; Christoph M; Wunderlich C; Salmas J; Gaspar T; Piorkowski C
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):505-7. PubMed ID: 25900994
    [No Abstract]   [Full Text] [Related]  

  • 14. Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Gasperetti A; Tandri H
    Card Electrophysiol Clin; 2022 Dec; 14(4):679-683. PubMed ID: 36396184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Romero J; Patel K; Briceno D; Alviz I; Gabr M; Diaz JC; Trivedi C; Mohanty S; Della Rocca D; Al-Ahmad A; Yang R; Rios S; Cerna L; Du X; Tarantino N; Zhang XD; Lakkireddy D; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2022-2031. PubMed ID: 32478430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
    Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death.
    Pappone C; Ciconte G; Anastasia L; Gaita F; Grant E; Micaglio E; Locati ET; Calovic Z; Vicedomini G; Santinelli V
    Europace; 2023 Mar; 25(3):948-955. PubMed ID: 36610790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia.
    Pokushalov E; Romanov A; Turov A; Artyomenko S; Shirokova N; Karaskov A
    Heart Rhythm; 2010 Oct; 7(10):1406-10. PubMed ID: 20601157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial voltage ratio in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Müssigbrodt A; Bertagnolli L; Efimova E; Kosiuk J; Dinov B; Bode K; Kircher S; Dagres N; Döring M; Richter S; Sommer P; Husser D; Bollmann A; Hindricks G; Arya A
    Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):219-224. PubMed ID: 28536891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endo/epicardial ablation of ventricular arrhythmias with contact force-sensing catheters in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Aras D; Özcan F; Çay S; Özeke Ö; Kara M; Topaloğlu S
    Anatol J Cardiol; 2019 Mar; 21(4):187-195. PubMed ID: 30930451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.